Eko Health, a cardiopulmonary digital health company, announced on 10 November that it raised $65m in a series C round to close the gap between virtual and in-person care.
In January, Eko received US Food and Drug Administration clearance for its AI-powered algorithms that, combined with Eko’s digital stethoscopes, allow health providers to more
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?